Skip to main content

Table 4 Comparison of indicators in different MoCA score groups

From: Increased level of serum asymmetric dimethylarginine in individuals with more severe cognitive impairment, as evaluated using Montreal Cognitive Assessment instead of Mini-Mental State Examination

Variable

1(n = 62)

2(n = 37)

3(n = 31)

4(n = 42)

χ2/F

P

Variable

Age[y, (P25, P75)]

61.5(52,64)

73(63,80)a

70(62,76)a

62(56,74)bc

62(56,65)bc

24.3821

< 0.0001*

Sex(male/female)

4(40)/6(60)

21(48.84)/22(51.16)

24(61.54)/15(38.46)

30(63.83)/17(36.17)

20(60.61)/13(39.39)

3.5748

0.4489

Education level (y)(≥12)

6(60)

41(95.35)a

37(94.87)a

40(85.11)

20(60.61)bcd

24.9557

< 0.000*

Hypertension

3(30)

31(72.09)

26(66.67)

35(74.47)

19(57.58)

9.0705

0.0594

Coronary heart disease

4(40)

16(37.21)

12(30.77)

22(46.81)

12(36.36)

2.4599

0.6518

Diabetes mellitus

0(0)

12(27.91)

7(17.95)

11(23.4)

4(12.12)

5.9498

0.2029

Smoking

2(20)

21(48.84)

16(41.03)

27(57.45)

14(42.42)

5.8712

0.2090

Drinking

4(40)

17(39.53)

15(38.46)

23(48.94)

11(33.33)

2.1702

0.7045

Stroke or cerebral infarction

3(30)

25(58.14)

23(58.97)

24(51.06)

12(36.36)

6.4494

0.1680

Hypohepatia

3(30)

4(9.3)

2(5.13)

3(6.38)

0(0)

--

0.0369*

Renal dysfunction

2(20)

5(11.63)

2(5.13)

2(4.26)

4(12.12)

--

0.2932

Thyroid dysfunction

0(0)

4(9.3)

4(10.26)

1(2.13)

3(9.09)

--

0.4567

Family history of dementia

1(10)

2(4.65)

5(12.82)

5(10.64)

6(18.18)

--

0.4205

Other family history

8(80)

13(30.23)a

19(48.72)

25(53.19)b

18(54.55)b

10.6144

0.0313*

Hight [ cm, (P25, P75)]

163.5(160,175)

165(158,170)

166(160–170)

165(160–170)

169(160–175)

6.6330

0.1566

Weight(kg)

60(58–75)

60(54–70)

69.5(60–71)

70(60–75)

70(60–75)

9.1741

0.0569

SBP [mmHg, (P25, P75)]

128(120,140)

140(121,150)

147(140,160)ab

142(130,160)a

140(130,140)c

11.0435

0.0261*

DBP [mmHg, (P25, P75)]

80(78,90)

85(80,90)

90(80,91)

83(80,96)

80(80,90)

3.3197

0.5058

Glu(mmol/L)

5.63(5.23–5.78)

5.48(4.95–7.05)

5.35(4.93–6.57)

6.43(5.08–7.93)

5.67(5.14–6.4)

4.4125

0.3530

TG(mmol/L)

1.34(0.93–1.8)

1.2(0.98–2.05)

1.14(0.94–1.94)

1.59(1.07–2.13)

1.4(1.14–2.16)

2.8574

0.5820

T-CH(mmol/L)

4.38(3.74–5.16)

4.95(3.92–5.39)

4.39(3.64–5.09)

4.42(4.07–4.85)

4.75(4.25–5.34)

4.3797

0.3571

LDL-C(mmol/L)

2.46(1.84–3.22)

3.07(2.48–3.6)

2.6(2.21–3.65)

2.93(2.56–3.26)

2.89(2.58–3.36)

4.6499

0.3251

HDL-C(mmol/L)

1.18(0.87–1.66)

1.1(0.95–1.33)

1.1(0.88–1.38)

1.16(0.94–1.36)

1.16(1.04–1.38)

2.4658

0.6508

BUN(mmol/L)

5.01(4.21–5.59)

5.81(4.73–6.89)

5.73(4.76–6.97)

6.21(4.95–7.08)

5.01(4.34–7.15)

8.0485

0.0898

Cr(umol/L)

73.3(55.9–84.4)

80(66.8–96.9)

84.4(69-96.4)

82.3(67.9–96)

73.6(64.7–89.1)

3.8055

0.4330

ALT(U/L)

19.5(16–35)

12(8–20)a

18(12–23)b

19(13–26)b

17(14–25)b

13.1867

0.0104*

AST(U/L)

20.5(15–30)

13(11–17)a

17(13–22)b

18(13–23)b

17(13–22)b

13.1339

0.0106*

WBC (109/L)

7.15(4.1-8)

7(6.2–8.2)

7.4(5.6–8.2)

7.4(6.1–8.8)

6.7(5.8–8.2)

2.2924

0.6821

CRP(mg/L)

1.51(0.67–1.59)

2.28(1.39–4.95)

1.83(0.65–6.35)

2.35(0.94–4.85)

1.55(0.83–2.42)

7.1093

0.1302

ADMA concentration(umol/L)

43.65(36.17–53.74)

56.76(47.65–65.74)a

58.49(42.94–66.13)a

55.51(46.13–60.63)

47.9(37.93–57.63)bc

10.1315

0.0383*

GFR(ml/min)

52.61(24.56–84.16)

58.23(37.75–82.17)

75.27(35.39–96.12)

73.49(37.56-100.39)

62.75(37.98–97.35)

3.3183

0.5060

Ccr(ml/min)

83.26 ± 22.28

61.72 ± 22.7a

68.46 ± 21.15

74.26 ± 21.7b

83.32 ± 26.25bc

5.1816

0.0006*

MMSE score(P25, P75)

29.5(29,30)

18(15,22)a

23(21,25)ab

25(24,27)abc

26(26,27)abcd

103.030

< 0.0001*

MoCA score(P25, P75)

26(25,28)

10(9,12)a

15(14,16)ab

19(18,20)abc

23(23,24)abcd

161.500

< 0.0001*

Adjustive MMSE

30(29–30)

19(16–23)a

24(22–26)ab

26(25–27)abc

27(26–28)abcd

96.3713

< 0.0001*

(Based on years of schooling)

26.5(26–29)

11(10–13)a

16(15–17)ab

20(19–21)abc

24(23–25)abcd

162.270

< 0.0001*

  1. Note compared with level 1 group, aP<0.05; compared with level 2 group, bP<0.05; compared with level 3 group, cP<0.05; compared with level 4 group, dP<0.05